Fluoxymesterone as third line endocrine therapy for advanced breast cancer. A phase II trial of the Piedmont Oncology Association von SCHIFELING, D. J, JACKSON, D. V, ZEKAN, P. J, MUSS, H. B

Volltext

Methotrexate content in squamous cell carcinoma of the head and neck after low-dose methotrexate von Schifeling, David J., George, Todd, McGuirt, Fred, Capizzi, Robert L., Kamen, Barton A.

Volltext

Common cancers—Genetics, origin, prevention, screening: Parts I and II von Schifeling, David J., Horton, John, Tafelski, Thomas J.

Volltext

Clinician and staff perspectives on potential disparities introduced by the rapid implementation of telehealth services during COVID-19: a mixed-methods analysis von Phimphasone-Brady, P, Chiao, J, Karamsetti, L, Sieja, A, Johnson, R, Macke, L, Lum, H, Lee, R, Farro, S, Loeb, D, Schifeling, C, Huebschmann, A G

Volltext

Measuring Physician Mental Workload: Reliability and Validity Assessment of a Brief Instrument von Bertram, Dennis A., Opila, Donald A., Brown, Jeffrey L., Gallagher, Susan J., Schifeling, Richard W., Snow, Irene S., Hershey, Charles O.

Volltext

Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast von Shapiro, C. M., Schifeling, D., Bitran, J. D., Desser, R. K., Rochman, H., Michel, A., Shapiro, R., Evans, R., Kozloff, M. F., Recant, W., Billings, A. A.

Volltext

Multimodality therapy of stage III adenocarcinoma of the breast von Bitran, J. D., Desser, R. K., Schifeling, D., Shapiro, C. M., Kozloff, M. F., Robin, E., Recant, W., Michel, A., Rochman, H., Billings, A. A.

Volltext